Citigroup
FCSC

Citigroup’s Fibrocell Science Inc. FCSC Stock Holding History

Citigroup’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,438
Closed -$54K – 7632
2016
Q1 		$54K Buy
1,438
+1,249
+661% +$49.9K ﹤0.01% 6082
2015
Q4 		$12K Sell
189
-3,489
-95% -$251K ﹤0.01% 6756
2015
Q3 		$212K Sell
3,678
-21
-0.6% -$1.86K ﹤0.01% 4443
2015
Q2 		$292K Sell
3,699
-188
-5% -$12.7K ﹤0.01% 4148
2015
Q1 		$263K Sell
3,887
-1,615
-29% -$104K ﹤0.01% 4278
2014
Q4 		$213K Sell
5,502
-1,413
-20% -$57.1K ﹤0.01% 4640
2014
Q3 		$301K Sell
6,915
-879
-11% -$41.2K ﹤0.01% 3928
2014
Q2 		$466K Buy
7,794
+2,096
+37% +$117K ﹤0.01% 3518
2014
Q1 		$447K Sell
5,698
-481
-8% -$37.3K ﹤0.01% 3582
2013
Q4 		$376K Buy
6,179
+704
+13% +$41K ﹤0.01% 4064
2013
Q3 		$360K Buy
5,475
+8
+0.1% +$647 ﹤0.01% 3701
2013
Q2 		$502K Buy
+5,467
New +$452K ﹤0.01% 3479

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's FCSC Position: Q2 2016 in Review

Citigroup sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 1,438 shares — an estimated $54K sold.

Citigroup first reported a position in FCSC in Q2 2013 and held it in 12 quarters. The position peaked at $502K in Q2 2013. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

  • Citigroup reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 1,438 Fibrocell Science Inc. shares in Q2 2016, an estimated $54K.
  • Citigroup first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 12 quarters.
  • Citigroup's Fibrocell Science Inc. position peaked at $502K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.